Precision medicine: the rifle vs. shotgun approach to cancer treatment

Why does one person respond favorably to lung cancer treatment while another does not?

The answer lies in their DNA.

Just 20 years ago, lung cancer was broadly categorized into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Relatively recently, the treatment of NSCLC shifted from chemotherapy as a single treatment option to treatment with precision medicine, which is positively impacting survival rates.

Read more…